S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

ACST Acasti Pharma Inc

3.37

0.00 (0.00%)

Nov 21 2024 - Closed

Delayed by 15 minutes

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Acasti Pharma (NASDAQ:ACST)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Acasti Pharma Charts.

Acasti Pharma (NASDAQ:ACST)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Acasti Pharma Charts.

Acasti Pharma Inc News

Form 8-K - Current report
Monday 28 October 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 25 October 2024 (1 month ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Tuesday 15 October 2024 (1 month ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Tuesday 8 October 2024 (2 months ago) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Tuesday 8 October 2024 (2 months ago) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Tuesday 8 October 2024 (2 months ago) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Tuesday 8 October 2024 (2 months ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Tuesday 8 October 2024 (2 months ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Tuesday 8 October 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 30 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 25 September 2024 (2 months ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Friday 6 September 2024 (3 months ago) • Edgar (US Regulatory)

More Acasti Pharma Inc News Articles

Marvell Technology

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions